When blood was treated with SFLLRN, CD62P was found to be elevated in individuals with advanced insulin resistance at 15,017 ± 5602 compared with mild insulin resistance (6304 ± 3478; p=0.01) or no insulin resistance (5226 ± 2565; p=0.007) (Fig. 2a). The gene discussed is SELP; the disease is Insulin resistance.